A glowing light bulb full of ideas
The Signal

Expert insights and opinions on clinical research and drug development.

Expert insights and opinions on clinical research and drug development.

Month: August 2021

EMA Draft Guidance: Here’s What It Tells Us About BYOD

The European Medicines Agency (EMA) draft guidance released this past June on “computerized systems and electronic data in clinical trials” to replace their 2010 reflection paper on…

Direct-to-Patient Clinical Supply Distribution: Everything You Need to Know

The adoption of decentralized studies has rapidly increased thanks in part to the recent pandemic, which encouraged regulators to permit more flexibility within protocols and forced sponsors to implement…

The Inaugural IMAGINE FORUM Recap

At Signant Health, we believe progress is best done together. That’s why we launched the Imagine Forum to promote industry-wide collaboration and thoughtful discussion.  …

AAIC 2021 Recap

Here are a few takeaways from Signant’s presentations that you may have missed: Dr. Miller led a product showcase, Glimmers…

Key Technology Elements for Successful Hybrid Trials

As the industry continues to predict and debate what the “new normal” in clinical development will look like in an…

Mixing eCOA Modes: How to Respond Post-COVID Mitigation

Over the early months of the pandemic, we worked with clients to implement mitigations for studies that continued but were…

Best Practices: RTSM Strategies to Avoid Partially Unblinding Clinical Trials

Randomization and Trial Supply Management (RTSM) solutions are routinely used in today’s clinical trials to manage randomization, enable emergency code break to…